Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit) (Unaudited) - USD ($)	Preferred Stock [Member] Series B Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Beginning balance, value at Dec. 31, 2019		$ 55,739	$ 3,039,163	$ (4,894,881)	$ (11,622)	$ (1,811,601)
Beginning balance, shares at Dec. 31, 2019		5,573,915
Common stock issued for accounts payable		$ 859	172,623			173,482
Common stock issued for accounts payable, shares		85,942
Warrants issued in conjunction with notes payable			32,149			32,149
Beneficial conversion feature issued with note payable			17,851			17,851
Consideration paid pursuant to amalgamation agreement
Foreign exchange loss					(12,698)	(12,698)
Net loss				(1,098,461)		(1,098,461)
Ending balance, value at Mar. 31, 2020		$ 56,598	3,261,786	(5,993,342)	(24,320)	(2,699,278)
Ending balance, shares at Mar. 31, 2020		5,659,857
Beginning balance, value at Dec. 31, 2019		$ 55,739	3,039,163	(4,894,881)	(11,622)	(1,811,601)
Beginning balance, shares at Dec. 31, 2019		5,573,915
Common stock issued for accounts payable						173,482
Foreign exchange loss						(30,077)
Net loss						(2,482,187)
Common stock issued in conjunction with note payable modification						45,725
Ending balance, value at Sep. 30, 2020		$ 59,482	3,770,127	(7,377,068)	(41,699)	(3,589,158)
Ending balance, shares at Sep. 30, 2020		5,948,220
Beginning balance, value at Mar. 31, 2020		$ 56,598	3,261,786	(5,993,342)	(24,320)	(2,699,278)
Beginning balance, shares at Mar. 31, 2020		5,659,857
Foreign exchange loss					(10,069)	(10,069)
Net loss				(818,391)		(818,391)
Common stock issued in conjunction with note payable modification		$ 122	45,603			45,725
Common stock issued in conjunction with note payable modification, shares		12,167
Ending balance, value at Jun. 30, 2020		$ 56,720	3,307,389	(6,811,733)	(34,389)	(3,482,013)
Ending balance, shares at Jun. 30, 2020		5,672,024
Foreign exchange loss					(7,310)	(7,310)
Net loss				(565,335)		(565,335)
Private equity placement		$ 369	227,131			227,500
Private equity placement, shares		36,871
Conversion of related party advance and notes payable		$ 2,393	235,607			238,000
Conversion of related party advance and notes payable, shares		239,325
Ending balance, value at Sep. 30, 2020		$ 59,482	3,770,127	(7,377,068)	(41,699)	(3,589,158)
Ending balance, shares at Sep. 30, 2020		5,948,220
Beginning balance, value at Dec. 31, 2020	$ 32,754	$ 100,951	15,222,770	(11,759,557)	(181,277)	3,415,641
Beginning balance, shares at Dec. 31, 2020	3,275,407	10,095,109
January 2021 registered direct offering, shares		2,221,334
February 2021 registered direct offering, shares		3,007,026
Stock based compensation			3,591,565			3,591,565
Induced conversion of stock options into restricted stock awards			298,714			298,714
Conversion of Series B Preferred Stock	$ (32,754)	$ 32,754
Conversion of Series B Preferred Stock, shares	(3,275,407)	3,275,407
Exercise of warrants, shares		851,099
Foreign exchange loss					35,736	35,736
Net loss				(3,250,711)		(3,250,711)
Ending balance, value at Mar. 31, 2021		$ 194,499	33,952,988	(15,010,268)	(145,541)	18,991,678
Ending balance, shares at Mar. 31, 2021		19,449,975
January 2021 registered direct offering, net		$ 22,213	4,594,874			4,617,087
February 2021 registered direct offering , net		30,070	6,986,331			7,016,401
Exercise of warrants, net		8,511	3,258,734			3,267,245
Beginning balance, value at Dec. 31, 2020	$ 32,754	$ 100,951	15,222,770	(11,759,557)	(181,277)	3,415,641
Beginning balance, shares at Dec. 31, 2020	3,275,407	10,095,109
Common stock issued for accounts payable
Conversion of stock options into restricted stock						$ 6,966,721
Exercise of options, shares						143,796
Foreign exchange loss						$ (4,036)
Net loss						(6,871,406)
Common stock issued in conjunction with note payable modification
Ending balance, value at Sep. 30, 2021		$ 313,836	73,869,289	(18,630,963)	(185,313)	55,366,849
Ending balance, shares at Sep. 30, 2021		31,383,632
Beginning balance, value at Mar. 31, 2021		$ 194,499	33,952,988	(15,010,268)	(145,541)	18,991,678
Beginning balance, shares at Mar. 31, 2021		19,449,975
Stock based compensation			717,466			717,466
Conversion of stock options into restricted stock		$ 421	(421)
Conversion of stock options into restricted stock, shares		42,125
Exercise of warrants		$ 17,921	7			17,928
Exercise of warrants, shares		1,791,948
Exercise of options		$ 1,342	(1,342)
Exercise of options, shares		134,246
Stock issued for services		$ 141	33,326			33,467
Stock issued for service, shares		14,121
Foreign exchange loss					(33,262)	(33,262)
Net loss				(908,289)		(908,289)
Ending balance, value at Jun. 30, 2021		$ 214,324	34,702,024	(15,918,557)	(178,803)	18,818,988
Ending balance, shares at Jun. 30, 2021		21,432,415
Consideration paid pursuant to amalgamation agreement		$ 99,512	38,942,770			39,042,282
Consideration paid pursuant to amalgamation agreement, shares		9,951,217
Stock based compensation			486,986			486,986
Reserve for Ameri warrant liabilities			(262,491)			(262,491)
Foreign exchange loss					(6,510)	(6,510)
Net loss				(2,712,406)		(2,712,406)
Ending balance, value at Sep. 30, 2021		$ 313,836	$ 73,869,289	$ (18,630,963)	$ (185,313)	$ 55,366,849
Ending balance, shares at Sep. 30, 2021		31,383,632